SGHT

Sight Sciences Inc

SGHT, USA

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

https://www.sightsciences.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SGHT
stock
SGHT

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from Brokerages MarketBeat

Read more →
SGHT
stock
SGHT

Patterns Watch: What is the fair value of SGHT stock now - Portfolio Return Report & Fast Entry High Yield Stock Tips moha.gov.vn

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$6.4167

Analyst Picks

Strong Buy

2

Buy

0

Hold

6

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

6.60

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-12.71 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-7.03 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-44.65 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Low

0.81

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 45.25% of the total shares of Sight Sciences Inc

1.

KCK Ltd

(8.3544%)

since

2025/06/30

2.

Long Focus Capital Management, LLC

(6.0181%)

since

2025/06/30

3.

BlackRock Inc

(4.8709%)

since

2025/06/30

4.

Vanguard Group Inc

(3.4451%)

since

2025/06/30

5.

Vanguard Total Stock Mkt Idx Inv

(1.891%)

since

2025/07/31

6.

iShares Russell 2000 ETF

(1.7916%)

since

2025/08/31

7.

B Group, Inc

(1.7759%)

since

2025/06/30

8.

Prosight Management, LP

(1.6646%)

since

2025/06/30

9.

Americana Partners, LLC

(1.6497%)

since

2025/06/30

10.

Geode Capital Management, LLC

(1.6151%)

since

2025/06/30

11.

Apollo Management Holdings LP

(1.2823%)

since

2025/06/30

12.

State Street Corp

(1.2484%)

since

2025/06/30

13.

Renaissance Technologies Corp

(0.8689%)

since

2025/06/30

14.

Fidelity Small Cap Index

(0.7937%)

since

2025/06/30

15.

iShares Russell 2000 Growth ETF

(0.6806%)

since

2025/08/31

16.

Northern Trust Corp

(0.65%)

since

2025/06/30

17.

Morgan Stanley - Brokerage Accounts

(0.6366%)

since

2025/06/30

18.

Vanguard Institutional Extnd Mkt Idx Tr

(0.6305%)

since

2025/07/31

19.

Dimensional Fund Advisors, Inc.

(0.574%)

since

2025/06/30

20.

Charles Schwab Investment Management Inc

(0.5085%)

since

2025/06/30

21.

D. E. Shaw & Co LP

(0.4846%)

since

2025/06/30

22.

Vanguard Russell 2000 ETF

(0.3774%)

since

2025/07/31

23.

Fidelity Extended Market Index

(0.3246%)

since

2025/07/31

24.

Gotham Asset Management, LLC

(0.2988%)

since

2025/06/30

25.

State St Russell Sm Cap® Indx SL Cl I

(0.288%)

since

2025/08/31

26.

Schwab US Small-Cap ETF™

(0.2719%)

since

2025/08/30

27.

JPMorgan Chase & Co

(0.2554%)

since

2025/06/30

28.

Bank of America Corp

(0.2018%)

since

2025/06/30

29.

Schwab Small Cap Index

(0.1978%)

since

2025/07/31

30.

NT R2000 Index Fund - NL

(0.1907%)

since

2025/06/30

31.

Bridgeway Capital Management, LLC

(0.1841%)

since

2025/06/30

32.

iShares Micro-Cap ETF

(0.1798%)

since

2025/08/31

33.

Bridgeway Ultra-Small Company Market

(0.1729%)

since

2025/06/30

34.

NT R2000 Index Fund - DC - NL - 3

(0.152%)

since

2025/06/30

35.

iShares Russell 2000 Small-Cap Idx Instl

(0.1367%)

since

2025/07/31

36.

iShares U.S. Small-Cap Eq Fac ETF

(0.1331%)

since

2025/08/31

37.

Extended Equity Market Fund K

(0.1325%)

since

2025/06/30

38.

Fidelity Total Market Index

(0.1107%)

since

2025/07/31

39.

Russell 2500™ Index Fund F

(0.1035%)

since

2025/06/30

40.

DFA US Small Cap I

(0.1003%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.2188

Latest Release

Date

2025-09-30

EPS Actual

-0.16

EPS Estimate

-0.26

EPS Difference

0.1

Surprise Percent

38.4615%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(3)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(2.5)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.